Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxSelling, General & Administrative
Others
Ratios

Groove Botanicals (GRVE) EBIT (2016 - 2017)

Groove Botanicals' EBIT history spans 8 years, with the latest figure at -$60905.0 for Q1 2017.

  • For Q1 2017, EBIT rose 97.46% year-over-year to -$60905.0; the TTM value through Mar 2017 reached -$237176.0, up 91.44%, while the annual FY2025 figure was -$130834.0, 50.92% up from the prior year.
  • EBIT for Q1 2017 was -$60905.0 at Groove Botanicals, up from -$121394.0 in the prior quarter.
  • Across five years, EBIT topped out at -$25470.0 in Q3 2016 and bottomed at -$2.4 million in Q1 2016.
  • The 5-year median for EBIT is -$116109.0 (2015), against an average of -$252149.2.
  • The largest annual shift saw EBIT crashed 2907.44% in 2016 before it skyrocketed 97.46% in 2017.
  • A 5-year view of EBIT shows it stood at -$123970.0 in 2013, then soared by 30.25% to -$86469.0 in 2014, then plummeted by 63.98% to -$141789.0 in 2015, then grew by 14.38% to -$121394.0 in 2016, then skyrocketed by 49.83% to -$60905.0 in 2017.
  • Per Business Quant, the three most recent readings for GRVE's EBIT are -$60905.0 (Q1 2017), -$121394.0 (Q4 2016), and -$25470.0 (Q3 2016).